| Ticker Details |
|
Invivyd, Inc.
|
| IPO Date: |
August 6, 2022 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$437.08M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.08 | 5.07%
|
| Avg Daily Range (30 D): |
$0.08 | 4.14%
|
| Avg Daily Range (90 D): |
$0.09 | 4.56%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.37M |
| Avg Daily Volume (30 D): |
2.78M |
| Avg Daily Volume (90 D): |
5.25M |
| Trade Size |
| Avg Trade Size (Sh.): |
311 |
| Avg Trade Size (Sh.) (30 D): |
256 |
| Avg Trade Size (Sh.) (90 D): |
271 |
| Institutional Trades |
| Total Institutional Trades: |
88 |
| Avg Institutional Trade: |
$2.37M |
| Avg Institutional Trade (30 D): |
$.98M |
| Avg Institutional Trade (90 D): |
$1.67M |
| Avg Institutional Trade Volume: |
1.11M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.53M |
| Avg Closing Trade (30 D): |
$.76M |
| Avg Closing Trade (90 D): |
$4M |
| Avg Closing Volume: |
2.06M |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.45
|
$-.06
|
$-.12
|
|
Diluted EPS
|
$-.45
|
$-.06
|
$-.12
|
|
Revenue
|
$50.04M
|
$13.13M
|
$11.79M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-59.86M
|
$-10.47M
|
$-14.66M
|
|
Operating Income / Loss
|
$-62.23M
|
$-11.02M
|
$-15.06M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-21.91M
|
$50.06M
|
$-13.18M
|
|
PE Ratio
|
|
|
|
|
|
|